{
    "2021-07-16": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Lilly",
                        "Atopic Dermatitis",
                        "Delays",
                        "FDA"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie, Lilly face fresh delays in FDA approval for expanded use of arthritis drugs",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Lilly",
                        "FDA",
                        "arthritis drugs",
                        "delays"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Incyte",
                        "baricitinib",
                        "atopic dermatitis",
                        "New Drug Application"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: NVO & LLY's Small Acquisitions, JNJ's Sunscreens Recall",
                "features": {
                    "keywords": [
                        "Pharma",
                        "NVO",
                        "LLY",
                        "Acquisitions",
                        "JNJ",
                        "Sunscreens Recall"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}